China is one of the best destinations to outsource preclinical work, Outsourcing-Pharma.com reported from this year's CPhI trade in Milan. The article summarizes the comments on this area from experts at CPhI and reviewed recent movements of leading Chinese CROs in this area.

------------------------------------------------------------------------------------

This is not an article published by Pharma China, and please visit the following website link for the full text of the article.  The availability of the article is under the control of its publisher.  

http://www.outsourcing-pharma.com/news/ng.asp?n=80470-manipal-acunova-eli-lilly-china-preclinical

Note: By clicking on the above link, you will leave Pharma China Online. If you wish to return to this website, please click on "Back" button or log onto Pharma China Online again.